Europe Haematococcus Pluvialis Market by Product (Astaxanthin Ingredients {Oleoresin, Beadlets}), Astaxanthin Bulk Finished Products {Capsules, Tablets}), Application (Nutraceuticals, Aquaculture, Cosmetics, Food), and Geography— Forecast to 2030

Europe Haematococcus Pluvialis Market by Product (Astaxanthin Ingredients {Oleoresin, Beadlets}), Astaxanthin Bulk Finished Products {Capsules, Tablets}), Application (Nutraceuticals, Aquaculture, Cosmetics, Food), and Geography— Forecast to 2030

Europe Haematococcus Pluvialis Market by Product (Astaxanthin Ingredients {Oleoresin, Beadlets}), Astaxanthin Bulk Finished Products {Capsules, Tablets}), Application (Nutraceuticals, Aquaculture, Cosmetics, Food), and Geography— Forecast to 2030

According to the research report titled, ‘Europe Haematococcus Pluvialis Market by Product (Astaxanthin Ingredients {Oleoresin, Beadlets}), Astaxanthin Bulk Finished Products {Capsules, Tablets}), Application (Nutraceuticals, Aquaculture, Cosmetics, Food), and Geography— Forecast to 2030,’ in terms of value, the Europe Haematococcus pluvialis market is projected to reach $35.0 million by 2030, at a CAGR of 13.4% from 2023 to 2030, while in terms of volume, this market is projected to reach 241.44 tons by 2030, at a CAGR of 14.5% from 2023 to 2030. The report provides an in-depth analysis of the Haematococcus pluvialis market across Europe, current market trends, size, recent developments, and the forecast till 2030.

Succeeding extensive secondary and primary research and an in-depth analysis of the market scenario, the report conducts the impact analysis of the key industry drivers, restraints, opportunities, and challenges.

The growth of this market is driven by increasing demand for natural astaxanthin for nutraceuticals, growing demand for natural food colorants, and increasing awareness of clean-label products. However, the high production cost is expected to restrain the growth of this market.

The rising demand for natural astaxanthin and the growing use of natural astaxanthin in poultry and aquaculture is expected to create market growth opportunities. However, the complex production process for Haematococcus pluvialis is a major challenge for the players operating in this market. Additionally, the increasing need for natural self-grooming products is a prominent trend in the Europe Haematococcus pluvialis market.

Based on product, the Europe Haematococcus pluvialis market is mainly segmented into astaxanthin ingredients and astaxanthin bulk finished products. In 2023, the astaxanthin ingredients segment is expected to account for the largest share of the Europe Haematococcus pluvialis market. The large share of this segment is mainly attributed to the growing end-use applications of astaxanthin ingredients, rising awareness about preventive healthcare & nutraceuticals, rising demand for natural antioxidants, growing cosmetic & personal care markets, and government initiatives to support the aquaculture industry.

Based on application, the Europe Haematococcus pluvialis market is segmented into nutraceuticals, aquaculture and animal feed, cosmetics, food and beverages, and pharmaceuticals. In 2023, the nutraceuticals segment is expected to account for the largest share of the Europe Haematococcus pluvialis market. The large market share of this segment is primarily attributed to the increasing demand for natural astaxanthin derived from haematococcus in the nutraceuticals industry. This demand is driven by the potential health benefits that astaxanthin may provide, including its effects on various diseases such as cancers, hypertension, diabetes, cardiovascular and gastrointestinal disorders, neurodegenerative diseases, and certain skin conditions.

An in-depth geographic analysis of the market provides detailed qualitative and quantitative insights into the ten major countries/regions in Europe (Germany, the U.K., Italy, France, Sweden, Spain, Russia, Netherlands, Denmark, Poland, and the Rest of Europe). The U.K. is expected to witness significant growth during the forecast period, mainly due to the rapidly growing vegan population, people’s drive towards maintaining a healthy dietary regime, and the well-established F&B industry.

The key players operating in the Europe Haematococcus pluvialis market are E.I.D. - Parry (India) Limited (A Subsidiary of M/S. Ambadi Investments Limited) (India), Cyanotech Corporation (U.S.), YUNNAN GREEN A BIOLOGICAL PROJECT CO., LTD. (Yunnan Spirin Biotechnology Co. Ltd) (China), Sun Chlorella Corporation (Japan), Roquette Klötze GmbH & Co. KG (Germany), Tianjin Norland Biotech Co., Ltd (China), Aliga Microalgae (Denmark), DAESANG Corporation (Korea), BlueBioTech Group (Germany), Algatechnologies Ltd. (A Part of Solabia Group) (Israel), AstaReal Group (Japan), BEIJING GINGKO GROUP (BGG) (U.S.), FENCHEM (China), PIVEG, Inc. (U.S.), Algamo s.r.o. (Czech Republic), Algalíf Iceland ehf. (Part of Sana Pharma Industries) (Iceland), Atacama Bio Natural Products S.A. (Chile), BDI BioLife Science GmbH (Austria), Sea & Sun Organic GmbH (Subsidiary of Sea & Sun Technology GmbH) (Germany), Pond Technologies Inc. (Canada), Algicel, Biotecnologia e Investigação, Lda (Portugal), and Astaxa GmbH (Germany).

Key Questions Answered in the Report-

What is the revenue generated by the Europe Haematococcus pluvialis market?
At what rate is the Europe demand for Haematococcus pluvialis projected to grow for the next 5-7 years?
What is the historical market size and growth rate for the Europe Haematococcus pluvialis market?
What are the major factors impacting the growth of this market?
What are the major opportunities for existing players and new entrants in the market?
Which product and application segments create major traction for the manufacturers in this market?
What are the key country-level trends in this market? Which countries are expected to offer significant growth opportunities for the manufacturers operating in the Europe Haematococcus pluvialis market?
Who are the major players in the Europe Haematococcus pluvialis market? What are their specific product offerings in this market?
What recent developments have taken place in the Europe Haematococcus pluvialis market? What are the impacts of these strategic developments on the market?

Scope of the Report:

Europe Haematococcus Pluvialis Market—by Product

Astaxanthin Ingredients
Astaxanthin Oleoresin
Beadlets
Whole Biomass Powder
Water Dispersible Powder
Astaxanthin Bulk Finished Products
Capsules/Softgels
Tablets

Europe Haematococcus Pluvialis Market—by Application

Nutraceuticals
Aquaculture and Animal Feed
Cosmetics
Food & Beverages
Pharmaceuticals

Europe Haematococcus Pluvialis Market—by Geography

Germany
U.K.
Italy
France
Sweden
Spain
Russia
Netherlands
Denmark
Poland
Rest of Europe (RoE)

Europe Haematococcus Pluvialis Market - Report Summary

Report Metrics	Details
Years Considered	2023 - 2030
Base Year	2022
Forecast Period	2023-2030
Page Count	161
Units Referenced	Value (USD Thousand), Volume (Thousand Tons)
Segments/Key Topics	Market by Product, Market by Application, Market by Country
Regions Covered	Germany, the U.K., Italy, France, Sweden, Spain, Russia, the Netherlands, Denmark, Poland, and the Rest of Europe
Key Companies Mentioned	E.I.D. - Parry (India) Limited (A Subsidiary of M/S. Ambadi Investments Limited) (India), Cyanotech Corporation (U.S.), YUNNAN GREEN A BIOLOGICAL PROJECT CO., LTD. (Yunnan Spirin Biotechnology Co. Ltd) (China), Sun Chlorella Corporation (Japan), Roquette Klötze GmbH & Co. KG (Germany), Tianjin Norland Biotech Co., Ltd (China), Aliga Microalgae (Denmark), DAESANG Corporation (Korea), BlueBioTech Group (Germany), Algatechnologies Ltd. (A Part of Solabia Group) (Israel), AstaReal Group (Japan), BEIJING GINGKO GROUP (BGG) (U.S.), FENCHEM (China), PIVEG, Inc. (U.S.), Algamo s.r.o. (Czech Republic), Algalíf Iceland ehf. (Part of Sana Pharma Industries) (Iceland), Atacama Bio Natural Products S.A. (Chile), BDI BioLife Science GmbH (Austria), Sea & Sun Organic GmbH (Subsidiary of Sea & Sun Technology GmbH) (Germany), Pond Technologies Inc. (Canada), Algicel, Biotecnologia e Investigação, Lda (Portugal), and Astaxa GmbH (Germany). (Portugal), Algae to Omega, LLC (U.S.), Shaivaa Algaetech LLP (India), and Astaxa GmbH (Germany).Australia Pty Limited (Australia), Hangzhou Ouqi Food Co., Ltd. (China), and Shaanxi Rebecca Bio-Tech Co., Ltd (China)

FAQs About the Report

What is the Focus of Europe Haematococcus Pluvialis Market Report?

This report provides detailed market insights and market sizes & forecasts of the Europe haematococcus pluvialis market segmented by product, application, and geography. In this study, we have considered the revenue of haematococcus pluvialis biomass sold in Europe in the form of astaxanthin ingredients and astaxanthin bulk finished products. The application of these products includes nutraceuticals, aquaculture and animal feed, cosmetics, food & beverages, and pharmaceuticals.

What are the Market Size and CAGR of the Europe Haematococcus Pluvialis Market for 2023–2030?

The Haematococcus pluvialis market is projected to reach $35.0 million by 2030, at a CAGR of 13.4% during the forecast period.

Which is the High-growth Application Segment of the Europe Haematococcus Pluvialis Market?

Based on the application, the nutraceutical segment is expected to witness the fastest growth rate during the forecast period.

What are the Major Drivers for this Market?

Some of the key drivers of this market are increasing demand for natural astaxanthin for nutraceuticals, growing demand for natural food colorants, and increasing awareness of clean-label products

What is the Major Restraint for the Europe Haematococcus Pluvialis Market?

The key restraint of this market is high production cost

Who are the Major Players Operating in the Europe Haematococcus Pluvialis Market?

The key players operating in the Europe haematococcus pluvialis market are E.I.D. - Parry (India) Limited (A Subsidiary of M/S. Ambadi Investments Limited) (India), Cyanotech Corporation (U.S.), YUNNAN GREEN A BIOLOGICAL PROJECT CO., LTD. (Yunnan Spirin Biotechnology Co. Ltd) (China), Sun Chlorella Corporation (Japan), Roquette Klötze GmbH & Co. KG (Germany), Tianjin Norland Biotech Co., Ltd (China), Aliga Microalgae (Denmark), DAESANG Corporation (Korea), BlueBioTech Group (Germany), Algatechnologies Ltd. (A Part of Solabia Group) (Israel), AstaReal Group (Japan), BEIJING GINGKO GROUP (BGG) (U.S.), FENCHEM (China), PIVEG, Inc. (U.S.), Algamo s.r.o. (Czech Republic), Algalíf Iceland ehf. (Part of Sana Pharma Industries) (Iceland), Atacama Bio Natural Products S.A. (Chile), BDI BioLife Science GmbH (Austria), Sea & Sun Organic GmbH (Subsidiary of Sea & Sun Technology GmbH) (Germany), Pond Technologies Inc. (Canada), Algicel, Biotecnologia e Investigação, Lda (Portugal), and Astaxa GmbH (Germany).

Which is the High-growth Country in the Market?

The U.K. is expected to witness a significant growth rate during the forecast period, mainly due to its rapidly growing vegan population, people’s drive towards maintaining a healthy dietary regime, and the well-established F&B industry.